CRF receptor blockers can block the activation of noradrenergic neurons induced by stress, CRFR1 or CRFR2 antagonists can restore the expression of net to normal level and increase the level of NE (Huang et al., 2015), so as to further play a regulatory role in depression. The gene discussed is CRHR1; the disease is major depressive disorder.